JENNIFER RHOTEN: Open Payments
NPI 1861948838 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 25 payments from 10 companies in 2025. Trend: 2023 $1,162 · 2024 $748 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Amgen Inc. | 5 | $86 |
| Novo Nordisk Inc | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: OTEZLA, VRAYLAR, XIFAXAN, Ozempic, MOUNJARO, Cologuard Collection Kit, Wegovy, ELIQUIS.
Industry payments across PA — which companies pay providers there.
